Cargando…

Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors

The Hippo pathway is a critical transcriptional signaling pathway that regulates cell growth, proliferation and organ development. The transcriptional enhanced associate domain (TEAD) protein family consists of four paralogous transcription factors that function to modulate gene expression in respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holden, Jeffrey K., Cunningham, Christian N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876656/ https://www.ncbi.nlm.nih.gov/pubmed/29558384 http://dx.doi.org/10.3390/cancers10030081

Ejemplares similares

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

Autopalmitoylation of TEAD Proteins Regulates Transcriptional Output of Hippo Pathway
por: Chan, PuiYee, et al.
Publicado: (2016)

Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation
por: Lin, Kimberly C., et al.
Publicado: (2017)

Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer
por: Wu, Yujian, et al.
Publicado: (2021)

Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming
por: Singh, Vivek P., et al.
Publicado: (2021)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023)

Regulation of TEAD Transcription Factors in Cancer Biology
por: Huh, Hyunbin D., et al.
Publicado: (2019)

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
por: Kang, Wei, et al.
Publicado: (2018)

Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
por: Fan, Mengyang, et al.
Publicado: (2022)

Novel Allosteric Effectors Targeting Human Transcription Factor TEAD
por: Ibrahim, Mayar Tarek, et al.
Publicado: (2023)

IFN-γ-response mediator GBP-1 represses human cell proliferation by inhibiting the Hippo signaling transcription factor TEAD
por: Unterer, Bea, et al.
Publicado: (2018)

Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations
por: Troilo, Albino, et al.
Publicado: (2016)

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer
por: González-Alonso, Paula, et al.
Publicado: (2020)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

Tead transcription factors differentially regulate cortical development
por: Mukhtar, Tanzila, et al.
Publicado: (2020)

VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
por: Jiao, Shi, et al.
Publicado: (2017)

HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway
por: Geng, Hui, et al.
Publicado: (2021)

Emerging roles of TEAD transcription factors and its coactivators in cancers
por: Pobbati, Ajaybabu V., et al.
Publicado: (2013)

Leveraging Hot Spots of TEAD–Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling
por: Zhao, Bin, et al.
Publicado: (2023)

A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation
por: Qi, Yangfan, et al.
Publicado: (2016)

Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

Members of the TEAD family of transcription factors regulate the expression of Myf5 in ventral somitic compartments
por: Ribas, Ricardo, et al.
Publicado: (2011)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

The role of lysine palmitoylation/myristoylation in the function of the TEAD transcription factors
por: Mesrouze, Yannick, et al.
Publicado: (2022)

RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling
por: Choi, Sunkyung, et al.
Publicado: (2022)

The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
por: Cao, Zhifa, et al.
Publicado: (2023)

The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility
por: Al-Mathkour, Marwah M., et al.
Publicado: (2022)

VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway
por: Xu, Kaicheng, et al.
Publicado: (2020)

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
por: Figeac, Nicolas, et al.
Publicado: (2019)

The Hippo pathway as a target of the Drosophila DRE/DREF transcriptional regulatory pathway
por: Vo, Nicole, et al.
Publicado: (2014)

Retracted: VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway
por: of Inflammation, Mediators
Publicado: (2022)

The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis
por: Zhou, Yuhang, et al.
Publicado: (2016)

Robo signalling controls pancreatic progenitor identity by regulating Tead transcription factors
por: Escot, Sophie, et al.
Publicado: (2018)

Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD
por: Mesrouze, Yannick, et al.
Publicado: (2017)

Targeting the Hippo Pathway for Breast Cancer Therapy
por: Wu, Liqing, et al.
Publicado: (2018)

Repurposing of Drugs Targeting YAP-TEAD Functions
por: Elisi, Gian Marco, et al.
Publicado: (2018)

SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway
por: Yin, Lei, et al.
Publicado: (2020)

TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
por: Elster, Dana, et al.
Publicado: (2018)

Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex
por: Che, Kepeng, et al.
Publicado: (2022)

Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie
por: Sun, Xiaohan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e3t1a6jmfk5d28kod72tslemt0